Product
Arsenic Trioxide
Aliases
arsenic trioxide, IV Arsenic Trioxide, IV ATO, Trisenox®
Name
Arsenic trioxide
FDA Approved
Yes
2 clinical trials
18 organizations
1 drug
1 indication
3 documents
Indication
Acute Promyelocytic LeukemiaDrug
Arsenic TrioxideClinical trial
An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients With Acute Promyelocytic LeukemiaStatus: , Estimated PCD: 2024-01-03
Clinical trial
Frontline Oral Arsenic Trioxide-based Induction in Newly Diagnosed Acute Promyelocytic LeukaemiaStatus: Recruiting, Estimated PCD: 2025-12-31
Organization
Fresenius Kabi USA, LLC
Document
DailyMed Label: ARSENIC TRIOXIDEOrganization
AuroMedics Pharma LLCOrganization
Sandoz Inc. Document
DailyMed Label: Arsenic trioxideOrganization
Zydus Lifesciences LimitedOrganization
Amneal Pharmaceuticals LLCOrganization
Sagent PharmaceuticalsOrganization
Amring Pharmaceuticals Inc.Organization
Nexus Pharmaceuticals IncOrganization
Ingenus Pharmaceuticals, LLCOrganization
Sintetica US LLCOrganization
STI Pharma LLCOrganization
Athenex Pharmaceutical Division, LLC.Organization
Zydus Pharmaceuticals USA Inc.Document
DailyMed Label: TrisenoxOrganization
Cephalon, LLCOrganization
Novadoz Pharmaceuticals LLCOrganization
Gland Pharma Limited